Literature DB >> 18675282

Excitatory afferents to CA3 pyramidal cells display differential sensitivity to CB1 dependent inhibition of synaptic transmission.

Mackenzie E Hofmann1, Ben Nahir, Charles J Frazier.   

Abstract

Recent advances in immunohistochemical techniques have, contrary to earlier reports, positively identified CB1 receptors on glutamatergic terminals in the hippocampus. Further work has implicated these receptors in modulation of susceptibility to kainic acid induced seizures. Based on these results, the current study was designed to test the hypothesis that both exogenous and endogenous cannabinoids can selectively modulate glutamatergic afferents to CA3 pyramidal cells, and that such modulation is mediated by cannabinoid type 1 (CB1) receptors. Towards that end we employed either conventional or two-photon guided minimal stimulation techniques to isolate mossy fiber and/or associational/commissural (A/C) inputs to CA3 pyramidal cells. We report that bath application of WIN55,212-2 selectively inhibits minimally evoked A/C inputs to CA3 pyramidal cells, without significantly altering simultaneously recorded mossy fiber inputs. Further, we find that WIN55,212-2 mediated inhibition of A/C inputs is completely blocked by the CB1 selective antagonist AM-251 and absent in CB1(-/-) animals, suggesting a dependence on CB1 receptors. Finally, we demonstrate that depolarization of CA3 pyramidal cells leads to calcium dependent release of endogenous cannabinoids that transiently inhibit A/C mediated responses, and that this effect is also sensitive to both AM-251 and the muscarinic acetylcholine receptor antagonist atropine. To our knowledge this represents the first demonstration of depolarization induced suppression of excitation in area CA3 of the hippocampus. Collectively, these results provide new information relevant to developing a thorough understanding of how ECs modulate excitatory transmission in an area that is both essential for the acquisition of new memories and intimately involved in epileptogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675282      PMCID: PMC2610849          DOI: 10.1016/j.neuropharm.2008.07.007

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  36 in total

1.  Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells.

Authors:  A C Kreitzer; W G Regehr
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

2.  Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex.

Authors:  Joseph Trettel; Eric S Levine
Journal:  J Neurophysiol       Date:  2003-04       Impact factor: 2.714

3.  Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.

Authors:  R I Wilson; R A Nicoll
Journal:  Nature       Date:  2001-03-29       Impact factor: 49.962

4.  CB1 cannabinoid receptors and on-demand defense against excitotoxicity.

Authors:  Giovanni Marsicano; Sharon Goodenough; Krisztina Monory; Heike Hermann; Matthias Eder; Astrid Cannich; Shahnaz C Azad; Maria Grazia Cascio; Silvia Ortega Gutiérrez; Mario van der Stelt; Maria Luz López-Rodriguez; Emilio Casanova; Günther Schütz; Walter Zieglgänsberger; Vincenzo Di Marzo; Christian Behl; Beat Lutz
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

5.  Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability.

Authors:  Vivien Chevaleyre; Pablo E Castillo
Journal:  Neuron       Date:  2003-05-08       Impact factor: 17.173

6.  Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons.

Authors:  Attila Losonczy; Agota A Biró; Zoltan Nusser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

7.  Presynaptic inhibition of excitatory afferents to hilar mossy cells.

Authors:  Ben Nahir; Chinki Bhatia; Charles J Frazier
Journal:  J Neurophysiol       Date:  2007-04-18       Impact factor: 2.714

8.  Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.

Authors:  N Hájos; T F Freund
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

9.  Endocannabinoid-mediated metaplasticity in the hippocampus.

Authors:  Vivien Chevaleyre; Pablo E Castillo
Journal:  Neuron       Date:  2004-09-16       Impact factor: 17.173

10.  Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.

Authors:  Y Yanovsky; S Mades; U Misgeld
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  15 in total

1.  Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.

Authors:  Robert E Hampson; Frances Miller; Guillermo Palchik; Sam A Deadwyler
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

2.  Alterations in the hippocampal endocannabinoid system in diet-induced obese mice.

Authors:  Federico Massa; Giacomo Mancini; Helmut Schmidt; Frauke Steindel; Ken Mackie; Carlo Angioni; Stéphane H R Oliet; Gerd Geisslinger; Beat Lutz
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  Npas4 Is a Critical Regulator of Learning-Induced Plasticity at Mossy Fiber-CA3 Synapses during Contextual Memory Formation.

Authors:  Feng-Ju Weng; Rodrigo I Garcia; Stefano Lutzu; Karina Alviña; Yuxiang Zhang; Margaret Dushko; Taeyun Ku; Khaled Zemoura; David Rich; Dario Garcia-Dominguez; Matthew Hung; Tushar D Yelhekar; Andreas Toft Sørensen; Weifeng Xu; Kwanghun Chung; Pablo E Castillo; Yingxi Lin
Journal:  Neuron       Date:  2018-02-08       Impact factor: 17.173

4.  Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.

Authors:  Mackenzie E Hofmann; Chinki Bhatia; Charles J Frazier
Journal:  J Physiol       Date:  2011-06-06       Impact factor: 5.182

5.  Two distinct and activity-dependent mechanisms contribute to autoreceptor-mediated inhibition of GABAergic afferents to hilar mossy cells.

Authors:  Casie Lindsly; Charles J Frazier
Journal:  J Physiol       Date:  2010-06-14       Impact factor: 5.182

Review 6.  Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention.

Authors:  Mackenzie E Hofmann; Charles J Frazier
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

7.  Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis.

Authors:  Tamara Perez-Rosello; Charles T Anderson; Francisco J Schopfer; Yanjun Zhao; David Gilad; Sonia R Salvatore; Bruce A Freeman; Michal Hershfinkel; Elias Aizenman; Thanos Tzounopoulos
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

8.  Cannabinoid modulation of cortical adrenergic receptors and transporters.

Authors:  B A S Reyes; J C Rosario; P M T Piana; E J Van Bockstaele
Journal:  J Neurosci Res       Date:  2009-12       Impact factor: 4.164

9.  mGluR-mediated and endocannabinoid-dependent long-term depression in the hilar region of the rat dentate gyrus.

Authors:  Ben Nahir; Casie Lindsly; Charles J Frazier
Journal:  Neuropharmacology       Date:  2010-01-05       Impact factor: 5.250

10.  Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells.

Authors:  Noémi Holderith; Beáta Németh; Orsolya I Papp; Judit M Veres; Gergo A Nagy; Norbert Hájos
Journal:  J Physiol       Date:  2011-08-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.